Valproic Acid in Childhood Progressive Brain Tumors
Status:
Withdrawn
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The study investigates valproic acid added to radiation and temozolomide therapy (standard of
care) for progressive or recurrent pediatric brain tumors.